Clinical translation of fast-curable corneal glue for corneal penetrating injuries

The University of Illinois received a $1.2M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award supports the clinical translation of a fast-curable corneal glue designed to treat corneal penetrating injuries. This research initiative addresses a critical medical need by developing and advancing a therapeutic intervention from laboratory development toward clinical application, with work being conducted at the University of Illinois's Chicago campus.

As a translational research project funded through the DHA's broader biomedical research portfolio, this award represents the agency's commitment to innovative medical solutions with potential application to military service members and the general public. The three-year performance period allows the research team to conduct the necessary preclinical validation, regulatory pathway development, and preliminary clinical activities required to move this corneal adhesive technology toward clinical implementation and potential commercialization for ophthalmologic trauma care.